| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Richard H Bagger is Director at TNXP. Richard H Bagger's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $5K at current prices.
Net of sales, the TNXP filings show accumulation of 11,000 shares.
Richard H Bagger has 10 Form 4 filings on record from June 2020 to August 2026, all as Director at Tonix Pharmaceuticals (TNXP), 2020–2026.
The 10 reported transactions were 7 option or other derivative awards, 2 open-market purchases and 1 other transaction.
Counted by filing, the open-market trades come to 2 purchases worth about $22K and no sales.
The largest open-market purchase was 1,000 shares of TNXP at an average $12.60 on August 20, 2026, about $13K.